MDC
Asset Logo

Medlab Clinical Limited

🇦🇺 ASX

🧬 BIOTECHNOLOGY

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-18.09%
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Medlab Clinical Ltd. is a biotechnology company, which engages in the development of nutraceutical products for chronic diseases and mental health conditions. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. The firm is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.

📈 Performance

Price History

-78.00%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$6.60

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in MDC

4

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

20 weeks

💵 Average investment amount

$791

Last time a customer invested in MDC

121 days
MDC investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

50%

Less than 50k

50%
👶 Age of investors

18 - 25

25%

26 - 34

25%

35 - 90

50%
🙋 Legal gender of investors

Female

75%

Male

25%

Pearlers who invest in MDC also invest in...

Vanguard US Total Market Shares Index ETF

VTS

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

🙌 Performance (5Yr p.a)

16.79%

📊 Share price

$413.38 AUD

🇺🇸 UNITED STATES

🌏 GLOBAL

🤖 TECHNOLOGY

⛳️ DIVERSIFIED

📈 HIGH PRICE GROWTH

Find Out More

BHP Group Ltd. engages in the exploration, development, production and processing of iron ore, metallurgical coal, and copper. The company is headquartered in Melbourne, Victoria and currently employs 40,981 full-time employees. The firm is a producer of commodities, including iron ore, copper, nickel, potash and metallurgical (steelmaking) coal. The company is focused on offering a range of resources, which provides copper for renewable energy; nickel for electric vehicles; potash for sustainable farming, and iron ore and metallurgical coal for the steel needed for global infrastructure and the energy transition. Its segments include Copper, Iron Ore, and Coal. Its Copper segment is engaged in mining of copper, silver, zinc, molybdenum, uranium, and gold. Its Iron Ore segment is engaged in mining of iron ore. Its Coal segment is engaged in mining of metallurgical coal and energy coal. The firm is also focused on operating Olympic Dam, Prominent Hill, and Carrapateena underground copper-gold mines in South Australia. Its operations are situated in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and others.

🙌 Performance (5Yr p.a)

4.02%

📊 Share price

$40.37 AUD

⛏️ MINING

⚖️ HIGH GOVERNANCE

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

3.57%

📊 Share price

$66.42 AUD

⛳️ DIVERSIFIED

🕊️ SOCIALLY AWARE

🌏 GLOBAL

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

🙌 Performance (5Yr p.a)

4.24%

📊 Share price

$138.29 AUD

💸 FINANCIALS

⛳️ DIVERSIFIED

🇦🇺 AUSTRALIA

Orthocell Ltd. engages in the business of developing and commercializing biological medical devices and cell therapies. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-08-12. The firm is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The firm is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.

🙌 Performance (5Yr p.a)

4.00%

📊 Share price

$0.45 AUD

🧬 BIOTECHNOLOGY

Want more shares? Try these...

Middle Island Resources Ltd. is an exploration company, which engages in the business of identifying, acquiring, and exploring mineral assets. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-16. The firm is focused on copper and gold minerals. Its 100% owned Barkly Copper-Gold Super Project comprises approximately 16 exploration licenses (13 granted and three applications) cover an aggregate of 6,918 square kilometers (km2). The Barkly tenements extend from outcropping areas near Tennant Creek and the interpreted eastward extensions of prospective Proterozoic stratigraphy that includes the East Tennant Ridge and Burnette Downs Rift corridor beneath shallow to moderate depth Georgina Basin cover. Its prospects include Crosswinds, Eiger and Zermatt. The firm's subsidiary is Barkly Operations Pty Ltd.

🙌 Performance (5Yr p.a)

-18.26%

📊 Share price

$0.02 AUD

⛏️ MINING

MedAdvisor Ltd. engages in the provision of pharmacy-driven, innovative patient engagement solutions that simplify the patient medication journey to empower better health. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm's segments include Australia, the United States, the United Kingdom and Asia Operations. The firm's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The firm's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.

🙌 Performance (5Yr p.a)

155.56%

📊 Share price

$0.40 AUD

🩺 HEALTH CARE

🙌 Performance (5Yr p.a)

66.67%

📊 Share price

$0.03 AUD

📈 HIGH PRICE GROWTH

Mercury NZ Ltd. engages in the generation and distribution of electricity from hydro, geothermal, and gas. The company is headquartered in Tauranga, Bay Of Plenty and currently employs 1,512 full-time employees. The company went IPO on 2013-05-10. The firm is also a retailer of electricity, gas, broadband and mobile services to residential and small to medium-sized business customers. The firm is operating through the segments: Generation/Wholesale, Retail, and Other. The generation/wholesale market segment encompasses activity associated with the electricity production, electricity trading, generation development activities. The company also includes revenue from the sale of electricity, to both commercial & industrial customers. The retail market segment encompasses activity associated with sale of electricity, gas, telecommunication products/services and other related products and services to customers in New Zealand through Mercury and Trustpower brands. The Other segment represents corporate support services. The Company’s products include electricity, gas, broadband, and mobile.

🙌 Performance (5Yr p.a)

3.31%

📊 Share price

$5.42 AUD

🔋 UTILITIES

Compare
Add to watchlist